RxDoctor Payments Data

Richard Palmer, MD

Psychiatry · Torrance, CANPI 1881873081

Payments from drug & device makers

$1,619in general payments, 2019–2025

Across 18 payments — averaging $89.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$289
  • Johnson & Johnson$269
  • Seagen Inc.$240
  • AbbVie$238
  • Pfizer$212
  • Genentech USA, Inc.$150
  • plus $221 from 3 others

What the payments were for

  • Food & beverage$1,58998%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca3$289
Johnson & Johnson3$269
Seagen Inc.2$240
AbbVie(2 entities)4$238
Pfizer2$212
Genentech USA, Inc.1$150
Sanofi1$101
E.r. Squibb & Sons, L.L.C.1$92
Cvrx, Inc.1$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,619 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$114,901
Medicare patients
99
Services billed
1,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide11$5,292
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$2,975
Aripiprazole22$2,973
Bupropion XlBupropion Hcl105$2,840
Trazodone Hcl105$1,384
Escitalopram Oxalate86$1,035
Citalopram HbrCitalopram Hydrobromide106$948
Fluoxetine Hcl53$840
Lorazepam115$790
Phenelzine Sulfate22$744
Quetiapine Fumarate15$695
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$578
Duloxetine Hcl27$528
Clonazepam67$430
Alprazolam90$412

Paid to pharmacies, not to this prescriber.

Other psychiatry in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →